Classification structure-activity relations (C-SAR) in prediction of human intestinal absorption.

AB/HIA is a "soft" filter for identifying compounds with poor intestinal membrane permeability. The analyzed data set included over 1000 drug-like compounds with experimental human intestinal absorption (HIA) values. A sequence of recursive partitioning analyses based on multiple physicochemical and structural descriptors led to the derivation of the rule-based algorithm (filter). The obtained rules reveal a simple physicochemical model of intestinal permeability; they also account for the specific effects caused by quarternary nitrogens and biphosphonate groups. Comparison of the observed and predicted values revealed very low percent of disagreement (15% false-positives and 3% false-negatives). The unusual absorption of compounds that deviated from the predicted values was explained in terms of active transport, efflux, chemical stability, chelating ability, and solubility. Most of these effects can be accounted for by new, substructure-specific rules that can be added into the existing filter. This can lead to the development of a reliable theoretical model for predicting human intestinal absorption. If combined with other models for predicting first pass metabolism, the updated AB/HIA filter can be very useful in predicting oral bioavailability.

[1]  A. Moffat,et al.  Clarke's Isolation and identification of drugs in pharmaceuticals, body fluids, and post-mortem material , 1986 .

[2]  L. Benet,et al.  Active secretion and enterocytic drug metabolism barriers to drug absorption 1 PII of original artic , 1996 .

[3]  F R Jelovsek,et al.  Eliciting principles of hazard identification from experts. , 1990, Teratology.

[4]  A. Dantzig,et al.  Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells. , 1994, Biochimica et biophysica acta.

[5]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[6]  Arun K Mandagere,et al.  Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates. , 2002, Journal of medicinal chemistry.

[7]  C. Calhau,et al.  Characterization of the transport of the organic cation [3H]MPP+ in human intestinal epithelial (Caco-2) cells , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[9]  C. Tse,et al.  Nucleoside transport in human colonic epithelial cell lines: evidence for two Na+-independent transport systems in T84 and Caco-2 cells. , 1999, Biochimica et biophysica acta.

[10]  A. Seelig A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.

[11]  R. Neubert,et al.  Intestinal Transport of β-Lactam Antibiotics: Analysis of the Affinity at the H+/Peptide Symporter (PEPT1), the Uptake into Caco-2 Cell Monolayers and the Transepithelial Flux , 2004, Pharmaceutical Research.

[12]  A. Ghose,et al.  A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.

[13]  Thomas J. Raub,et al.  Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. , 1995, Journal of pharmaceutical sciences.

[14]  G Houin,et al.  Gastrointestinal absorption of drugs: methods and studies , 1999, Fundamental & Clinical Pharmacology.

[15]  I. Rosenberg,et al.  Carrier affinity as a mechanism for the pH-dependence of folate transport in the small intestine. , 1990, Biochimica et biophysica acta.

[16]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[17]  H. Takanaga,et al.  Transcellular Transport of Benzole Acid Across Caco-2 Cells by a pH-Dependent and Carrier-Mediated Transport Mechanism , 2004, Pharmaceutical Research.

[18]  H. Koepsell,et al.  Organic cation transporters in intestine, kidney, liver, and brain. , 1998, Annual review of physiology.

[19]  J. Beijnen,et al.  The pharmacological role of P-glycoprotein in the intestinal epithelium. , 1998, Pharmacological research.

[20]  Christophe G. Lambert,et al.  Analysis of a Large Structure/Biological Activity Data Set Using Recursive Partitioning , 1999, J. Chem. Inf. Comput. Sci..

[21]  J. Blake,et al.  Chemoinformatics - predicting the physicochemical properties of 'drug-like' molecules. , 2000, Current opinion in biotechnology.

[22]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[23]  Y. Tsuda,et al.  Mechanism of intestinal absorption of an orally active beta-lactam prodrug: uptake and transport of carindacillin in Caco-2 cells. , 1999, The Journal of pharmacology and experimental therapeutics.

[24]  A. Y. Lu,et al.  Role of pharmacokinetics and metabolism in drug discovery and development. , 1997, Pharmacological reviews.

[25]  J. Tolan,et al.  MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.

[26]  H. Takanaga,et al.  pH‐Dependent and Carrier‐mediated Transport of Salicylic Acid Across Caco‐2 Cells , 1994, The Journal of pharmacy and pharmacology.

[27]  Per Artursson,et al.  Selective Paracellular Permeability in Two Models of Intestinal Absorption: Cultured Monolayers of Human Intestinal Epithelial Cells and Rat Intestinal Segments , 1993, Pharmaceutical Research.

[28]  Kristina Luthman,et al.  Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.

[29]  Hans Lennernäs,et al.  Does Fluid Flow Across the Intestinal Mucosa Affect Quantitative Oral Drug Absorption? Is It Time for a Reevaluation? , 1995, Pharmaceutical Research.

[30]  S. Rubin,et al.  Transport of thiamine in human intestine: mechanism and regulation in intestinal epithelial cell model Caco-2. , 1999, American journal of physiology. Cell physiology.

[31]  U Norinder,et al.  Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.

[32]  D K Yu,et al.  The Contribution of P‐glycoprotein to Pharmacokinetic Drug‐Drug Interactions , 1999, Journal of clinical pharmacology.

[33]  R L Lipnick Correlative and mechanistic QSAR models in toxicology. , 1999, SAR and QSAR in environmental research.

[34]  Remigijus Didziapetris,et al.  Fragmental Methods in the Design of New Compounds. Applications of The Advanced Algorithm Builder , 2002 .

[35]  Tudor I. Oprea,et al.  Toward minimalistic modeling of oral drug absorption. , 1999, Journal of molecular graphics & modelling.

[36]  G. Koren,et al.  Pharmacokinetic Changes During Pregnancy and Their Clinical Relevance , 1997, Clinical pharmacokinetics.

[37]  Xin Chen,et al.  Recursive Partitioning Analysis of a Large Structure-Activity Data Set Using Three-Dimensional Descriptors1 , 1998, J. Chem. Inf. Comput. Sci..

[38]  H Lennernäs,et al.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.

[39]  G Beck,et al.  Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.

[40]  Peter C. Jurs,et al.  Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..

[41]  R. Neidlein,et al.  In vitro Studies of Poorly Absorbed Drugs Using Porcine Intestine in the Ring Model RIMO , 2000, Arzneimittelforschung.

[42]  J. Stein,et al.  Short-chain fatty acid (SCFA) uptake into Caco-2 cells by a pH-dependent and carrier mediated transport mechanism , 2000, European journal of nutrition.

[43]  B. H. Stewart,et al.  Atorvastatin Transport in the Caco-2 Cell Model: Contributions of P-Glycoprotein and the Proton-Monocarboxylic Acid Co-Transporter , 2000, Pharmaceutical Research.

[44]  Lawrence X. Yu,et al.  Predicting Human Oral Bioavailability of a Compound: Development of a Novel Quantitative Structure-Bioavailability Relationship , 2000, Pharmaceutical Research.

[45]  Xin Chen,et al.  Automated Pharmacophore Identification for Large Chemical Data Sets1 , 1999, J. Chem. Inf. Comput. Sci..

[46]  R. Lipnick Outliers: their origin and use in the classification of molecular mechanisms of toxicity. , 1991, The Science of the total environment.

[47]  James A. Platts,et al.  Estimation of Molecular Linear Free Energy Relation Descriptors Using a Group Contribution Approach , 1999, J. Chem. Inf. Comput. Sci..

[48]  Tudor I. Oprea,et al.  Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..

[49]  H. Takanaga,et al.  Stereoselective and Carrier-Mediated Transport of Monocarboxylic Acids Across Caco-2 Cells , 1996, Pharmaceutical Research.

[50]  J. Delarue,et al.  Mechanisms and kinetics of alpha-linolenic acid uptake in Caco-2 clone TC7. , 1997, Biochimica et biophysica acta.

[51]  Thomas J. Raub,et al.  Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. , 1994, Journal of pharmaceutical sciences.

[52]  L. Benet,et al.  Active secretion and enterocytic drug metabolism barriers to drug absorption. , 2001, Advanced drug delivery reviews.

[53]  H. van de Waterbeemd,et al.  Property-based design: optimization of drug absorption and pharmacokinetics. , 2001, Journal of medicinal chemistry.

[54]  Kin-Kai Hwang,et al.  A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. , 2002, European journal of medicinal chemistry.

[55]  A. Alex,et al.  Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6. , 1999, Journal of medicinal chemistry.

[56]  G Folkers,et al.  Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.